<DOC>
	<DOCNO>NCT02183311</DOCNO>
	<brief_summary>Study examine safety , tolerability , pharmacokinetics , pharmacodynamics BI 1356 BS administer healthy male volunteer single rise oral dos ( 1 mg , 2.5 mg , 5 mg , 10 mg ) multiple rise oral dos ( 2.5 mg , 5 mg , 10 mg daily 12 day )</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics , Pharmacodynamics Single Rising Oral Doses Multiple Rising Oral Doses BI 1356 BS Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Linagliptin</mesh_term>
	<criteria>Subjects healthy male volunteer meet criterion : Persons without clinically remarkable finding clinically evident complication base concurrent illness , past medical history , physical examination , vital sign ( blood pressure ( BP ) , pulse rate ( PR ) , body temperature ) , 12lead Electrocardiogram ( ECG ) , laboratory test result Persons 20 old 35 young Persons BMI 17.6 kg/m2 29.9 kg/m2 less Persons willing participate trial study initiation give write consent accordance GCP ( Good Clinical Practice , MHW Ordinance No . 28 date March 27 , 1997 ) Persons deviate norm show clinical finding ( BP , PR , ECG ) consultation Persons clinically relevant complication Persons gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immune , hormonal disorder Persons central nervous system disorder ( e.g. , epilepsy ) , mental disorder , neurological disorder Persons history significant orthostatic hypotension , syncopal attack , blackout Persons chronic infection severe acute infection Persons history severe allergy/hypersensitivity include allergy drug inactive ingredient Persons receive drug long halflife ( 24 hour ) within month treatment trial , within period 10 time longer halflife drug , study Persons receive drug may theoretically affect study result base information obtain time preparation protocol within 10 day treatment study Persons participate another trial investigational drug within 4 month treatment study Smokers ( smoke 10 cigarette 3 cigar 3 pipe per day ) Persons abstain smoke throughout study Persons undoubtedly abuse alcohol Persons abuse drug Persons donate blood 100 mL within 4 week treatment Persons perform rigorous exercise ( within week treatment study ) Persons laboratory test result outside reference range result consider clinically relevant change Persons obey diet rule trial site Persons ECG value outside reference range clinical importance . Examples include , limited , QRS interval &gt; 120 m</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>